We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
(+6.3%)
Cap. Flow
+$730M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$259M |
| 2 |
Vale
VALE
|
+$83M |
| 3 |
WPX
WPX Energy, Inc.
WPX
|
+$44.4M |
| 4 |
Gold Fields
GFI
|
+$39.7M |
| 5 |
Royal Gold
RGLD
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$109M |
| 2 |
Newmont
NEM
|
+$96M |
| 3 |
B
Barrick Mining
B
|
+$77.1M |
| 4 |
Franco-Nevada
FNV
|
+$63.2M |
| 5 |
GG
Goldcorp Inc
GG
|
+$58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 50.75% |
| 2 | Energy | 16.94% |
| 3 | Healthcare | 6.45% |
| 4 | Technology | 5.96% |
| 5 | Consumer Staples | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBT
76
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $63.3M | 0.3% |
7,166,975
+238,515
| +3% | +$2.36M |
|
77
Bunge Global
BG
$23.6B
| $63.1M | 0.3% |
905,508
+11,382
| +1% | +$815K |
|
78
Biogen
BIIB
$29.9B
| $62.1M | 0.29% |
213,908
+9,806
| +5% | +$2.76M |
|
79
Green Plains
GPRE
$1.19B
| $62.1M | 0.29% |
3,392,146
+14,541
| +0.4% | +$279K |
|
80
Qualcomm
QCOM
$176B
| $61.9M | 0.29% |
1,102,453
+202,545
| +23% | +$11.3M |
|
81
Texas Instruments
TXN
$255B
| $61.8M | 0.29% |
560,782
+41,381
| +8% | +$4.48M |
|
82
Broadcom
AVGO
$1.82T
| $60.8M | 0.28% |
2,505,770
+230,750
| +10% | +$5.66M |
|
83
Amazon
AMZN
$2.5T
| $59.5M | 0.28% |
700,080
-21,120
| -3% | -$1.68M |
|
84
HDFC Bank
HDB
$119B
| $58.4M | 0.27% |
2,224,416
+774,200
| +53% | +$19.3M |
|
85
Gilead Sciences
GILD
$161B
| $57.4M | 0.27% |
809,799
-29,167
| -3% | -$2.06M |
|
86
ASML
ASML
$675B
| $57.3M | 0.27% |
289,411
+15,320
| +6% | +$3.08M |
|
87
Archer Daniels Midland
ADM
$41.4B
| $56.2M | 0.26% |
1,226,431
+81,449
| +7% | +$3.66M |
|
88
Merck
MRK
$324B
| $56.1M | 0.26% |
968,893
+55,197
| +6% | +$3.11M |
|
89
JD.com
JD
$40.8B
| $55.6M | 0.26% |
1,426,249
-6,621
| -0.5% | -$255K |
|
|
MAG
90
DELISTED
MAG Silver
MAG
| $55.2M | 0.26% |
5,104,445
-373,711
| -7% | -$4.18M |
|
91
Micron Technology
MU
$1.04T
| $55.1M | 0.26% |
1,051,335
+5,664
| +0.5% | +$306K |
|
92
Pfizer
PFE
$140B
| $54.5M | 0.25% |
1,582,217
+170,314
| +12% | +$5.82M |
|
93
Eli Lilly
LLY
$1.07T
| $54.4M | 0.25% |
637,709
+50,207
| +9% | +$4.12M |
|
94
NXP Semiconductors
NXPI
$68B
| $53.1M | 0.25% |
485,717
+75,996
| +19% | +$8.38M |
|
95
Analog Devices
ADI
$181B
| $52.3M | 0.24% |
544,887
-2,012
| -0.4% | -$190K |
|
96
Applied Materials
AMAT
$426B
| $49.4M | 0.23% |
1,070,500
+120,800
| +13% | +$6.23M |
|
|
TFCFA
97
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $48.6M | 0.23% |
977,940
-173,198
| -15% | -$6.84M |
|
|
WPX
98
DELISTED
WPX Energy, Inc.
WPX
| $48.5M | 0.23% |
2,689,435
+2,594,946
| +2,746% | +$44.4M |
|
99
Lam Research
LRCX
$382B
| $48.2M | 0.23% |
2,786,740
+388,570
| +16% | +$7.48M |
|
|
ESV
100
DELISTED
Ensco Rowan plc
ESV
| $47.7M | 0.22% |
1,641,665
-866,469
| -35% | -$21.2M |
|
Similar funds
DAM
VanEck Associates's Q2 2018 Portfolio in Review
As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.
By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.
- VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
- VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
- VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
- VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
- VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
- VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
- VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.
Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.